Invention Grant
- Patent Title: Monoclonal antibodies to fibroblast growth factor receptor 2
-
Application No.: US16164530Application Date: 2018-10-18
-
Publication No.: US10689448B2Publication Date: 2020-06-23
- Inventor: Kyung Jin Kim , Wei-meng Zhao , Hangil Park , Maximiliano Vasquez
- Applicant: GALAXY BIOTECH, LLC
- Applicant Address: US CA Cupertino
- Assignee: GALAXY BIOTECH, LLC
- Current Assignee: GALAXY BIOTECH, LLC
- Current Assignee Address: US CA Cupertino
- Agency: Alston & Bird LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/574 ; A61K39/00
Abstract:
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Public/Granted literature
- US20190153105A1 MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2 Public/Granted day:2019-05-23
Information query
